Finance

Lists
Why is ACH down 6,28%?
Dive Deeper
ACH:NYSE
Accendra Health Inc
0,44 US$
-6,28%
(-0,030) 1D
0,44 US$
-0,52% (-0,0023)
After hours
Closed: 8 ოქტ, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACH...
Open
0,48 US$
High
0,49 US$
Low
0,44 US$
Mkt. cap
33,80 მლნ.
Avg. vol.
1,32 მლნ.
Volume
1,38 მლნ.
52-wk high
4,69 US$
52-wk low
0,44 US$
EPS
-3,93 US$
Beta
1,57
Shares outstanding
76,90 მლნ.
No. of employees
6 ათ.
Open
0,48 US$
High
0,49 US$
Low
0,44 US$
Mkt. cap
33,80 მლნ.
Avg. vol.
1,32 მლნ.
Volume
1,38 მლნ.
52-wk high
4,69 US$
52-wk low
0,44 US$
EPS
-3,93 US$
Beta
1,57
Shares outstanding
76,90 მლნ.
No. of employees
6 ათ.
News stories
From web sources and news partners
Profile
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019. Wikipedia
About Accendra Health Inc
CEOედვვარდ ეი პესიცკა
Employees6,5 ათ.
Founded1882
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to ACH in the past 3 months
Hold
Buy
0
Hold
4
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACH in the last 3 months.
Highest
Current 0,44 US$
1,50 US$ (+238,45%)
Average
1,45 US$ (+227,17%)
Lowest
1,30 US$ (+193,32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Cherny
Leerink Partners
Hold
Reiterated
-
-
09/18/2026
Kevin Caliendo
UBS
Hold
Maintained
1,50 US$
+238,4%
08/13/2026
Allen Lutz
Bank of America Securities
Sell
Maintained
1,30 US$
+193,3%
08/11/2026
Eric Coldwell
Robert W. Baird
Hold
Downgraded
1,50 US$
+238,4%
08/11/2026
Daniel Grosslight
Citi
Hold
Downgraded
1,50 US$
+238,4%
08/11/2026
Last report
10 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,19 US$ / -0,09 US$
-116,01%miss
Revenue / Est. (USD)
613,23 მლნ. / 627,37 მლნ.
-2,25%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
697,26 მლნ.
708,97 მლნ.
627,78 მლნ.
613,23 მლნ.
Cost of goods sold
375,07 მლნ.
385,71 მლნ.
349,75 მლნ.
349,83 მლნ.
Cost of revenue
375,07 მლნ.
385,71 მლნ.
349,75 მლნ.
349,83 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
265,84 მლნ.
273,20 მლნ.
255,23 მლნ.
243,56 მლნ.
Operating expense
265,84 მლნ.
302,42 მლნ.
284,46 მლნ.
272,79 მლნ.
Total operating expenses
640,90 მლნ.
688,13 მლნ.
634,21 მლნ.
622,62 მლნ.
Operating income
56,36 მლნ.
20,83 მლნ.
-6,43 მლნ.
-9,38 მლნ.
Other non operating income
-1,08 მლნ.
747,00 ათ.
-1,02 მლნ.
-643,00 ათ.
EBT including unusual items
-3,64 მლნ.
-7,97 მლნ.
-16,25 მლნ.
-87,63 მლნ.
EBT excluding unusual items
26,25 მლნ.
-6,35 მლნ.
-39,80 მლნ.
-44,56 მლნ.
Income tax expense
1,97 მლნ.
1,47 მლნ.
-9,78 მლნ.
1,44 მლნ.
Effective tax rate
-54,25%
-18,47%
60,19%
-1,65%
Other operating expenses
-
-
-
-
Net income
-150,28 მლნ.
-56,33 მლნ.
-6,47 მლნ.
-89,07 მლნ.
Net profit margin
-21,55%
-7,94%
-1,03%
-14,52%
Earnings per share
0,25
0,21
-0,04
-0,19
Interest and investment income
-
-
-
-
Interest expense
-29,03 მლნ.
-27,93 მლნ.
-32,35 მლნ.
-34,54 მლნ.
Net interest expenses
-29,03 მლნ.
-27,93 მლნ.
-32,35 მლნ.
-34,54 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
120,46 მლნ.
50,71 მლნ.
55,32 მლნ.
56,32 მლნ.
Gain or loss from assets sale
-7,06 მლნ.
-10,89 მლნ.
-55,51 მლნ.
-3,27 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები